N05.3
Unspecified nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified nephritic syndrome with diffuse mesangial proliferative glomerulonephritis is a kidney condition characterized by inflammation and proliferation of cells within the kidney's filtering units. This condition leads to impaired kidney function, potentially causing symptoms such as swelling and blood in the urine. It is classified under ICD-10 code N05.3 and requires medical evaluation for appropriate diagnosis and management.
Causes & Symptoms
Clinical Causes: Autoimmune disorders, such as systemic lupus erythematosus. Infections, including bacterial or viral infections that trigger immune responses in the kidneys. Certain medications or toxins that may induce kidney inflammation. Genetic predispositions that affect kidney tissue. Unknown reasons when no specific cause can be identified (idiopathic cases).
Key Symptoms: Blood in urine (hematuria) Foamy or dark-colored urine due to elevated protein levels Swelling in the ankles, feet, or around the eyes (edema) High blood pressure (hypertension) Reduced urine output General feeling of tiredness or malaise Potential weight gain from fluid retention
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical assessment and laboratory testing, including urinalysis to detect blood and protein in the urine, blood tests to evaluate kidney function, and imaging studies. A kidney biopsy may be necessary to confirm the presence of mesangial proliferation and to determine the extent of glomerular inflammation. These diagnostic steps help differentiate this condition from other kidney diseases.
Treatment Protocols: Treatment strategies focus on controlling inflammation, managing symptoms, and preventing further kidney damage. These may include: - Use of corticosteroids or other immunosuppressive medications to reduce immune-related inflammation. - Blood pressure management with antihypertensive drugs, especially those protecting kidney function. - Dietary modifications, such as reduced salt and protein intake, to lessen kidney workload. - Diuretics to control swelling and edema. - Regular monitoring of kidney function through laboratory tests. - In some cases, plasma exchange or other advanced therapies might be considered. It is essential to work closely with healthcare professionals to develop a tailored treatment plan based on the severity and underlying cause of the condition.
Clinical Advice & FAQs
Billing Guidance
Is N05.3 a billable ICD-10 code?
Yes, N05.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N05.3?
Clinical documentation must specify the nature of Unspecified nephritic syndrome with diffuse mesangial proliferative glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
